{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.18082"}, {"@name": "filename", "#text": "24922_okamotookubo_ce_me_bot_par.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "RESSALVA \n\nAtendendo solicita\u00e7\u00e3o do(a) \nautor(a), o texto completo desta tese \nser\u00e1 disponibilizado somente a partir \n\nde 23/05/2018. \n\n\n\nUNIVERSIDADE ESTADUAL PAULISTA \n\n\u201cJ\u00daLIO DE MESQUITA FILHO\u201d \n\nCampus de Botucatu  \n\nFaculdade de Medicina Veterin\u00e1ria e Zootecnia \n\nEFEITO ANALG\u00c9SICO DO PLASMA RICO EM PLAQUETAS E C\u00c9LULAS-\n\nTRONCO NA DOR CR\u00d4NICA DE C\u00c3ES COM DISPLASIA COXOFEMORAL \n\nCELINA EMIKO OKAMOTO OKUBO \n\nBOTUCATU \u2013 SP \n\nMaio 2016\n\n\n\nUNIVERSIDADE ESTADUAL PAULISTA \n\n\u201cJ\u00daLIO DE MESQUITA FILHO\u201d \n\nCampus de Botucatu  \n\nFaculdade de Medicina Veterin\u00e1ria e Zootecnia \n\nEFEITO ANALG\u00c9SICO DO PLASMA RICO EM PLAQUETAS E C\u00c9LULAS-\n\nTRONCO NA DOR CR\u00d4NICA DE C\u00c3ES COM DISPLASIA COXOFEMORAL \n\nCELINA EMIKO OKAMOTO OKUBO \n\nTese apresentada \u00e0 Faculdade de \nMedicina Veterin\u00e1ria e Zootecnia, \nUniversidade Estadual Paulista \u201cJ\u00falio \nde Mesquita Filho\u201d, Campus de \nBotucatu, para obten\u00e7\u00e3o do t\u00edtulo de \nmestre na \u00e1rea de Biotecnologia \nanimal.  \n\nOrientador: Prof. Titular Stelio Pacca Loureiro Luna \n\nCo-orientadora: Profa. Titular Fernanda da Cruz Landim \n\nBOTUCATU \u2013 SP \n\nMaio  2016\n\n\n\n\n\nUNIVERSIDADE ESTADUAL PAULISTA \n\n\u201cJ\u00daLIO DE MESQUITA FILHO\u201d \n\nCampus de Botucatu  \n\nFaculdade de Medicina Veterin\u00e1ria e Zootecnia \n\nEFEITO ANALG\u00c9SICO DO PLASMA RICO EM PLAQUETAS E C\u00c9LULAS-\n\nTRONCO NA DOR CR\u00d4NICA DE C\u00c3ES COM DISPLASIA COXOFEMORAL \n\nCelina Emiko Okamoto Okubo \n\nCandidata \n\nProf. Titular Stelio Pacca Loureiro Luna \n\nOrientador \n\nProfa. Titular Fernanda da Cruz Landim \n\nCo-orientadora \n\nBOTUCATU \u2013 SP \n\nMaio  2016\n\n\n\nUNIVERSIDADE ESTADUAL PAULISTA \n\n\u201cJ\u00daLIO DE MESQUITA FILHO\u201d \n\nCampus de Botucatu  \n\nFaculdade de Medicina Veterin\u00e1ria e Zootecnia \n\nEFEITO ANALG\u00c9SICO DO PLASMA RICO EM PLAQUETAS E C\u00c9LULAS-\n\nTRONCO NA DOR CR\u00d4NICA DE C\u00c3ES COM DISPLASIA COXOFEMORAL \n\nPrograma de P\u00f3s-Gradua\u00e7\u00e3o em Biotecnologia Animal \n\n\u00c1rea de Cirurgia e Anestesiologia Veterin\u00e1ria \n\nP\u00f3s Graduanda:  \n\nCelina Emiko Okamoto Okubo (Depto. Cirurgia e Anestesiologia Veterin\u00e1ria-FMVZ/ \n\nUNESP/ Botucatu) \n\nOrientador: \n\nProf. Titular Stelio Pacca Loureiro Luna (Depto. Cirurgia e Anestesiologia Veterin\u00e1ria-\n\nFMVZ/ UNESP/ Botucatu) \n\nCo-orientadora: \n\nProfa. Titular Fernanda da Cruz Landim (Depto. Reprodu\u00e7\u00e3o e Radiologia Veterin\u00e1ria. \n\nFMVZ/ UNESP/ Botucatu) \nEquipe: \n\nProfa. Titular Sheila Canevese Rahal (Depto. Cirurgia e Anestesiologia Veterin\u00e1ria-FMVZ/ \n\nUNESP/ Botucatu) \n\nDr. Leandro Maia (PG-Depto. Reprodu\u00e7\u00e3o Animal-FMVZ/ UNESP/ Botucatu) \n\nDr. Jean G. F. Joaquim (Depto. Cirurgia e Anestesiologia Veterin\u00e1ria-FMVZ/ UNESP/ Botucatu) \n\nM.V. Isadora Arruda  (PG-Depto. Reprodu\u00e7\u00e3o Animal. FMVZ/ UNESP/ Botucatu)\n\nM.V. Luciane dos Reis Mesquita (PG-Depto. Cirurgia e Anestesiologia Veterin\u00e1ria-FMVZ/\n\nUNESP/ Botucatu)\n\nProfa. Dra. Regina K. Takahira (Depto. Cl\u00ednica Veterin\u00e1ria- FMVZ/ UNESP/ Botucatu)\n\nM.V. Washington T. Kano (PG-Depto. Cirurgia e Anestesiologia Veterin\u00e1ria-FMVZ/ UNESP/\n\nBotucatu)\n\nM.V. Hugo S. Oliveira (Depto. Reprodu\u00e7\u00e3o e Radiologia Veterin\u00e1ria-FMVZ/ UNESP/ Botucatu)\n\n\n\nCelina Emiko Okamoto Okubo \n\nEFEITO ANALG\u00c9SICO DO PLASMA RICO EM PLAQUETAS E C\u00c9LULAS-\n\nTRONCO NA DOR CR\u00d4NICA DE C\u00c3ES COM DISPLASIA COXOFEMORAL \n\nDisserta\u00e7\u00e3o apresentada \u00e0 Faculdade de Medicina Veterin\u00e1ria e Zootecnia, \n\nUniversidade Estadual Paulista \u201cJ\u00falio de Mesquita Filho\u201d, Campus de \n\nBotucatu, para obten\u00e7\u00e3o do t\u00edtulo de Mestre.  \n\n__________________________________________ \n\nOrientador: Prof. Titular. Stelio Pacca Loureiro Luna \n\nComiss\u00e3o Examinadora \n\n______________________________________ \nProfa. Titular Sheila Canavese Rahal \n\nUniversidade Estadual Paulista \n\n______________________________________ \nProf. Dr. Jean Guilherme Fernandes Joaquim \n\nInstituto Bioethicus \u2013 Botucatu-SP \n\n______________________________________ \nProfa. Dra. Fabiana Ferreira de Souza \n\nUniversidade Estadual Paulista \n\n______________________________________ \nProfa. Dra. Bruna De Vita \n\nPesquisadora \n\nBotucatu, 23 de Maio de 2016.\n\n\n\n\t\n \u00a0 \t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDEDICAT\u00d3RIA \n\n  \n\n\u00c0 minha querida fam\u00edlia, pela paci\u00eancia e entendimento nos momentos de \n\naus\u00eancia. \n\nAo meu caro e eterno mestre Prof. Stelio Pacca Loureiro Luna que sempre com \n\nmuita sabedoria me recebe de bra\u00e7os abertos para iluminar meu caminho do \n\nconhecimento.  \n\n \n\n\u201cConhe\u00e7a todas as teorias, domine todas as t\u00e9cnicas, mas ao tocar uma alma \n\nhumana, seja apenas outra alma humana.\u201d \n\nCarl Jung\n\n\n\n\t\n \u00a0 \t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nAGRADECIMENTOS \n \n\n \u00c0 sincronicidade da vida, que faz com que uma situa\u00e7\u00e3o crie la\u00e7os de \n\namizade que duram uma vida toda. \n\n Aos meus pais, que com muita luz e convic\u00e7\u00e3o, desde o in\u00edcio me \n\nensinaram que o conhecimento abre portas inigual\u00e1veis. \n\n Ao meu esposo Maur\u00edcio e meu filho Leonardo que neste per\u00edodo \n\nconseguiram entender a necessidade de minha aus\u00eancia pela busca \n\nincessante de meus objetivos. \n\n Ao Prof. Stelio Pacca Loureiro Luna e \u00e0 Profa. Maria Lu\u00edsa Buffo de \n\nC\u00e1pua minha eterna gratid\u00e3o e carinho por todo apoio, sabedoria e amizade. \n\n Ao Prof. Jean Guilherme Fernandes Joaquim pelo ensinamento e \n\nexemplo incans\u00e1vel de buscar novas formas de ajudar nossos animais. \n\n \u00c0 Profa. Fernanda da Cruz Landim que com muita solicitude me permitiu \n\numa viv\u00eancia incr\u00edvel no laborat\u00f3rio de cultivo celular. \n\n \u00c0 Profa. Sheila Canavese Rahal por ser minha eterna professora de \n\nortopedia veterin\u00e1ria, e juntamente com a Luciane dos Reis Mesquita, permitiu \n\nque eu vivenciasse a experi\u00eancia da avalia\u00e7\u00e3o baropodom\u00e9trica. \n\n \u00c0s minhas queridas companheiras, Danielle Barberini, Marianne \n\nCamargos, Luciane dos Reis e Isadora Arruda que fizeram este per\u00edodo em \n\nBotucatu ficar mais acolhedor e divertido.  \n\n A todo departamento de Radiologia Veterin\u00e1ria do Hospital Veterin\u00e1rio \n\nda FMVZ, principalmente ao meu colega de p\u00f3s-gradua\u00e7\u00e3o Hugo Salvador \n\nOliveira, que permitiram a viabilidade dos exames radiogr\u00e1ficos com muita \n\nprontid\u00e3o.  \n\n  A todos os amigos da FMVZ UNESP Botucatu que compartilharam \n\ncomigo momentos dif\u00edceis e alegres nesta caminhada.  \n\n A todos os professores da FMVZ UNESP Botucatu que sempre me \n\ninspiraram a ser uma pessoa melhor e uma profissional mais dedicada. \n\n Aos meus inesquec\u00edveis Tchuky, Kelly, Fofinha, Lilica, Bob, Pitoco, Nala, \n\ne tamb\u00e9m a todos outros cachorros incr\u00edveis que tive a sorte de t\u00ea-los como \n\nmeus professores e que fizeram com que eu amasse tanto minha carreira \n\ncomo m\u00e9dica veterin\u00e1ria. \n\n\n\n\t\n \u00a0 \t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nLISTA DE ANEXOS \n\nP\u00e1gina \n\nANEXO 1- Escala Anal\u00f3gica Visual (EAV) da dor (EAVdor) e Escala Anal\u00f3gica Visual \n\n(EAV) de claudica\u00e7\u00e3o (EAVloc)-----------------------------------------------------------------------32 \n\nANEXO 2 - Breve Invent\u00e1rio de dor canina (BIDC)--------------------------------------------- 33 \n\nANEXO 3 - Indicador de Dor Cr\u00f4nica da Universidade de Helsink  (IDCH)-------------- 34 \n\nANEXO 4 - Escala Num\u00e9rica Descritiva (END)-------------------------------------------------- 35 \n\nANEXO 5 - Escala Anal\u00f3gica Visual (EAV) de dor \u00e0 palpa\u00e7\u00e3o (EAVpalp dor)---------- 36 \n\nANEXO 6 - Impress\u00e3o geral do propriet\u00e1rio sobre a qualidade de vida do c\u00e3o (IGP)- 36\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n\t\n \u00a0 \t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nLISTA DE ABREVIATURAS, SIGLAS E S\u00cdMBOLOS \n \n  \np         N\u00edvel de signific\u00e2ncia \n\n?                      Desvio padr\u00e3o \n\nBIDC        Breve Invent\u00e1rio de Dor Canina \n\nBVS         Biblioteca Virtual em Sa\u00fade \n\nCEUA        Comiss\u00e3o de \u00c9tica no Uso de Animais \n\nCT                   C\u00e9lula-tronco \n\nCTM-TAs        C\u00e9lulas-tronco mesenquimais derivadas de tecido adiposo \n\nDAD         Doen\u00e7a articular degenerativa \n\nDCF                Displasia coxofemoral \n\nDMSO             Dimetilsulf\u00f3xido \n\nDP         Distribui\u00e7\u00e3o do Peso \n\nEAV         Escala Anal\u00f3gica Visual \n\nEAVdor        Escala Anal\u00f3gica Visual para dor \n\nEAVloc        Escala Anal\u00f3gica Visual para claudica\u00e7\u00e3o \n\nEND         Escala Num\u00e9rica Descritiva \n\nFMVZ        Faculdade de Medicina Veterin\u00e1ria e Zootecnia \n\nKg                   Quilogramas \n\nIDCH               Indicador de Dor Cr\u00f4nica da Universidade de Helsink   \n\nIGP                 Impress\u00e3o Geral do Propriet\u00e1rio sobre a qualidade de vida do \n\nc\u00e3o \n\n\u00b5M                   Micr\u00f4metros \n\nmL                   Mililitros \n\n\u00b5L                    Microlitros \n\nn                      N\u00famero de animais  \n\nPBS                 Solu\u00e7\u00e3o Tamp\u00e3o Fosfato-salino \n\nPCR                 Rea\u00e7\u00e3o em Cadeia pela Polimerase  \n\nPDGF              Fator de Crescimento Derivado de Plaquetas \n\nPRP                 Plasma Rico em Plaquetas \n\nSFB                 Soro Fetal Bovino \n\nTGF-beta         Fator de Crescimento Transformador beta \n\nVEGF              Fator de Crescimento Vascular Endotelial\n\n\n\n\t\n \u00a0 \t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n \n\nSUM\u00c1RIO \n\n \n\nP\u00e1gina \n\nRESUMO------------------------------------------------------------------------------------11 \n\nABSTRACT---------------------------------------------------------------------------------12 \n\nCAP\u00cdTULO I \n\n1.  Introdu\u00e7\u00e3o-------------------------------------------------------------------------------14 \n\n2. Revis\u00e3o de literatura------------------------------------------------------------------14 \n\n2.1 \u2013Doen\u00e7a articular degenerativa (DAD) coxofemoral bilateral em \n\nc\u00e3es---------------------------------------------------------------------------------------14 \n\n2.2 -C\u00e9lulas-Tronco Mesenquimais derivadas de tecido adiposo (CTM-\n\nTAs)----------------------------------------------------------------------------------16 \n\n2.3 -Plasma Rico em Plaquetas (PRP)------------------------------------------18 \n\n3. Refer\u00eancias bibliogr\u00e1ficas-----------------------------------------------------------21 \n\n4. Anexos -----------------------------------------------------------------------------------32 \n\n \n\n CAP\u00cdTULO II \n\n1.    Artigo Cient\u00edfico-----------------------------------------------------------------------38\n\n \n\n \n\n \n\n \n\n \n\n\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n \n\nRESUMO \n\n \n\nOKAMOTO-OKUBO, C.E. Efeito analg\u00e9sico do plasma rico em plaquetas e \n\nc\u00e9lulas-tronco na dor cr\u00f4nica de c\u00e3es com displasia coxofemoral. 2016. \n\n66p. Disserta\u00e7\u00e3o (Mestrado) - Faculdade de Medicina Veterin\u00e1ria e Zootecnia, \n\nUniversidade Estadual Paulista \u201cJ\u00falio de Mesquita Filho\u201d, Botucatu, 2016. \n\nEste estudo cl\u00ednico, controlado, aleat\u00f3rio, duplo cego, investigou o efeito intra-\n\narticular do plasma rico em plaquetas (PRP) (n = 8) ou de c\u00e9lulas-tronco \n\nalog\u00eanicas (CT) (n = 8) na dor cr\u00f4nica de c\u00e3es com displasia coxofemoral \n\n(DCF) bilateral. Os propriet\u00e1rios avaliaram o Breve Invent\u00e1rio de Dor Canina \n\n(BIDC), o \u00cdndice de Dor Cr\u00f4nica de Helsink (IDCH), a Escala Anal\u00f3gica Visual \n\npara dor (EAVdor) e claudica\u00e7\u00e3o (EAVloc), e a Qualidade de Vida (QV). Uma \n\nm\u00e9dica veterin\u00e1ria avaliou a Escala Visual Anal\u00f3gica da dor \u00e0 palpa\u00e7\u00e3o \n\n(EAVpalp), a Escala Num\u00e9rica Descritiva para dor (END) e a porcentagem de \n\ndistribui\u00e7\u00e3o de peso corporal. As avalia\u00e7\u00f5es foram realizadas antes, aos 30 e \n\n60 dias ap\u00f3s o tratamento. Depois de CT, IDCH, EAVdor e EAVpalp foram \n\nreduzidos, QV aumentou aos 60 dias e BIDC reduziu aos 30 e 60 dias. Ap\u00f3s \n\nPRP, EAVloc e END reduziram em 60 dias e BIDC aos 30 e 60 dias. N\u00e3o \n\nhouve diferen\u00e7a entre os grupos. Ambos CT e PRP foram aparentemente \n\nben\u00e9ficos para reduzir a dor cr\u00f4nica em c\u00e3es que sofrem de DCF bilateral por \n\n60 dias, mas CT foi superior nas vari\u00e1veis de dor cr\u00f4nica em compara\u00e7\u00e3o com \n\nPRP. O benef\u00edcio cl\u00ednico de ambos os tratamentos \u00e9 que eles produzem um \n\nal\u00edvio da dor a longo prazo em c\u00e3es com DCF sem efeitos adversos aparentes. \n\n \n\nPalavras chave: C\u00e9lulas-tronco, inje\u00e7\u00f5es, intra-articular, coxofemoral, c\u00e3es \n\n\n\n\t\n \u00a0 \t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nABSTRACT \n\n \n\nAnalgesic effect of platelet-rich plasma and stem cells in chronic pain in \n\ndogs with hip dysplasia. 2016. 66p. Faculdade de Medicina Veterin\u00e1ria e \n\nZootecnia, Universidade Estadual Paulista \u201cJ\u00falio de Mesquita Filho\u201d, Botucatu, \n\n2015. \n\nThis randomized, controlled, double-blind clinical study investigated the effect of \n\nintra-articular platelet-rich plasma (PRP) (n=8) or allogeneic stem cells (SC) \n\n(n=8) in chronic pain of dogs with bilateral hip dysplasia (HD). The owners \n\nevaluated the Canine Brief Pain Inventory (CBPI), the Helsinki Chronic Pain \n\nIndex (HCPI), a Visual Analogue Scale for pain (VASpain) and lamness \n\n(VASloc) and the quality of life (QL). A veterinarian evaluated the Visual \n\nAnalogue Scale of pain in response to palpation (VASpalp), the descriptive \n\nnumerical scale for pain (DNS) and the percentage of body weight distribution. \n\nAll evaluations were performed before, at 30 and 60 days after treatment. After \n\nSC, HCPI, VASpain and VASpalp reduced and QL increased at 60 days and \n\nCBPI reduced at 30 and 60 days. After PRP, VASloc and DNS reduced at 60 \n\ndays and CBPI at 30 and 60 days. There was no difference between groups. \n\nBoth SCs and PRP were apparently beneficial to reduce chronic pain in dogs \n\nsuffering from bilateral hip dysplasia for 60 days, but SCs improved more \n\nchronic pain variables compared to PRP. The clinical benefit of both treatments \n\nis that they produce a long term pain relief in dogs with hip dysplasia with no \n\napparent adverse effects. \n\nKey words: Stem cells, injections, intra-articular, hip joint, dogs\n\n\n\n\t\n \u00a0 \t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nCAP\u00cdTULO  I\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n\t\n \u00a0\n\n14\t\n \u00a0\t\n \u00a0\n\n1. INTRODU\u00c7\u00c3O  \n\nA medicina regenerativa \u00e9 uma nova \u00e1rea das medicinas humana e \n\nveterin\u00e1ria e \u00e9 foco de estudos recentes, principalmente voltados para o uso da \n\nterapia de c\u00e9lulas-tronco mesenquimais derivadas de tecido adiposo (CTM-\n\nTAs), com o objetivo de tratar osteoartroses 1-20. Com esse mesmo foco, a \n\naplica\u00e7\u00e3o de Plasma Rico em Plaquetas (PRP) tamb\u00e9m \u00e9 amplamente utilizada \n\npara tratar problemas osteoarticulares n\u00e3o apenas no homem, mas tamb\u00e9m \n\nem diversas esp\u00e9cies como nos c\u00e3es 7,8,21-33. \n\nA dispasia coxofemoral (DCF) \u00e9 uma altera\u00e7\u00e3o n\u00e3o infecciosa e \n\nprogressiva que ocorre na cartilagem das articula\u00e7\u00f5es acometidas34. \n\nCaracteriza-se por uma sinovite e degenera\u00e7\u00e3o da cartilagem articular com \n\nperda da matriz, e que pode resultar na completa perda da superf\u00edcie \n\ncartilaginosa35.  \n\n A hip\u00f3tese deste estudo \u00e9 que as terapias com CTM-TAs alog\u00eanicas ou \n\nPRP s\u00e3o alternativas terap\u00eauticas eficazes e similares para controlar a dor e \n\nmelhorar a qualidade de vida em c\u00e3es com DCF bilateral 3,4. \n\n \n\n2. REVIS\u00c3O DE LITERATURA \n\n \n\n   2.1- Displasia coxofemoral (DCF) bilateral em c\u00e3es \n\nA displasia coxofemoral (DCF) \u00e9 uma enfermidade cr\u00f4nica, conhecida \n\ntamb\u00e9m como doen\u00e7a articular degenerativa (DAD)36. Estudos mostram a alta \n\npreval\u00eancia da DAD em c\u00e3es, com 20% da popula\u00e7\u00e3o canina acima de 1 ano \n\nde idade apresentando esta enfermidade em diferentes graus37. A DCF est\u00e1 \n\nrelacionada com dor cr\u00f4nica, claudica\u00e7\u00e3o, incapacidade funcional e redu\u00e7\u00e3o da \n\n\n\n\t\n \u00a0 \t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n21\t\n \u00a0\n\n3- REFER\u00caNCIAS BIBLIOGR\u00c1FICAS \n \n (Segundo normas Vancouver) \n \n\n1. Guercio A, Marco PD, Casella S, et al. Production of canine \n\nmesenchymal stem cells from adipose tissue and their application in dogs with \n\nchronic osteoarthritis of the humeroradial joints. Cell Bio Int. 2012;36:189\u2013194. \n\n2. Black LL, Gaynor J, Gahring D, et al. Effect of adipose-derived \n\nmesenchymal stem and regenerative cells on lameness in dogs with chronic \n\nosteoarthritis of the coxofemoral joints: a randomized, double-blinded, \n\nmulticenter, controlled trial. Vet Ther. 2007;4:272-284. \n\n3. Black  LL, Gaynor J, Adams C, et al. Effect of intraarticular injection of \n\nautologous adipose-derived mesenchymal stem and regenerative cells on \n\nclinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther. \n\n2008;9:192-200. \n\n4. Cuervo B, Rubio M, Sopena J, et al. Hip Osteoarthritis in Dogs: A \n\nRandomized Study Using Mesenchymal Stem Cells from Adipose Tissue and \n\nPlasma Rich in Growth Factors. Int J Mol Sci. 2014;15:13437-13460. \n\n5. Vilar JM, Batista M, Morales M, et al. Assessment of the effect of \n\nintraarticular injection of autologous adipose-derived mesenchymal stem cells in \n\nosteoarthritic dogs using a double blinded force platform analysis. BMC Vet \n\nRes. 2014;10. \n\n6. Vilar JM, Morales M, Santana A, et al. Controlled, blinded force platform \n\nanalysis of the effect of intraarticular injection of autologous adipose-derived \n\nmesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs. \n\nBMC Vet Res. 2013;9. \n\n\n\n\t\n \u00a0\n\n22\t\n \u00a0\t\n \u00a0\n\n7. Upchurch DA. Administration of adipose-derived stromal vascular \n\nfraction and platelet rich plasma in dogs with coxofemoral osteoarthritis. \n\nDepartment of Clinical Sciences. 2015. \n\n8. Yun S, Ku SK, Kwon YS. Adipose-derived mesenchymal stem cells and \n\nplatelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis \n\nin Beagle dogs. J Orthop Surg Res. 2016;11:9. \n\n9. Uth K, Trifonov D. Stem cell application for osteoarthritis in the knee \n\njoint: A minireview. World J Stem Cells. 2014;6:629-636. \n\n10. Tsai S-Y, Huang Y-C, Chueh L-L, et al. Intra-articular transplantation of \n\nporcine adipose-derived stem cells for the treatment of canine osteoarthritis: A \n\npilot study. World J Transplant. 2014;4:196-205. \n\n11. Bornes TD, Adesida AB, Jomha NM. Mesenchymal stem cells in the \n\ntreatment of traumatic articular cartilage defects: a comprehensive review. \n\nArthritis Res Ther. 2014;16. \n\n12. Lee JK, Responte DJ, Cissell DD, et al. Clinical translation of stem cells: \n\ninsight for cartilage therapies. Crit Rev Biotechnol 2014;34:89\u2013100. \n\n13. Wood JA, Chung D-J, Park SA, et al. Periocular and Intra-Articular \n\nInjection of Canine Adipose-Derived Mesenchymal Stem Cells: An In Vivo \n\nImaging and Migration Study. J Ocul Pharmacol Ther. 2012;28. \n\n14. Kim I, Bang SI, Lee SK, et al. Clinical implication of allogenic \n\nimplantation of adipogenic differentiated adipose-derived stem cells. Stem Cells \n\nTransl Med. 2014;3:1312-1321. \n\n15. Shen W, Chen J, Zhu I, et al. Intra-Articular Injection of Human Meniscus \n\nStem/Progenitor Cells Promotes Meniscus Regeneration and Ameliorates \n\n\n\n\t\n \u00a0\n\n23\t\n \u00a0\t\n \u00a0\n\nOsteoarthritis Through Stromal Cell-Derived Factor-1/CXCR4- Mediated \n\nHoming. Stem Cells Transl Med. 2014;3:387\u2013394. \n\n16. Qi Y, Feng G, Yan W. Mesenchymal stem cell-based treatment for \n\ncartilage defects in osteoarthritis. Mol Biol Rep. 2012;39:5683\u20135689. \n\n17. Whitworth DJ, Banks TA. Stem cell therapies for treating osteoarthritis: \n\nPrescient or premature? Vet J. 2014;202:416\u2013424. \n\n18. Shenaq DS, Rastegar F, Petkovic D, et al. Mesenchymal progenitor cells \n\nand their orthopedic applications: Forging a Path towards Clinical Trials. Stem \n\nCells Int. 2010. \n\n19. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. \n\nArthritis Res Ther. 2008;10. \n\n20. Carrade DD, Owens SD, Galuppo LD, et al. Clinicopathologic findings \n\nfollowing intra-articular injection of autologous and allogeneic placentally \n\nderived equine mesenchymal stem cells in horses. Cytotherapy. 2011;13:419-\n\n430. \n\n21. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection \n\ngrafts for musculoskeletal injuries: a review. Curr Rev Musculoskeletal Med. \n\n2008;1:165-174. \n\n22. Drengk A, Zapf A, Sturmer EK, et al. Influence of platelet-rich plasma on \n\nchondrogenic differentiation and proliferation of chondrocytes and \n\nmesenchymal stem cells. Cells Tissues Organs. 2009;189:317-326. \n\n23. Aziz Aly LA, El-Menoufy H, Hassan A, et al. Influence of autologus \n\nadipose derived stem cells and PRP on regeneration of dehiscence-type \n\ndefects in alveolar bone: A Comparative Histochemical and Histomorphometric \n\nStudy in Dogs. Int J Stem Cells. 2011;4:61-69. \n\n\n\n\t\n \u00a0\n\n24\t\n \u00a0\t\n \u00a0\n\n24. Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra-articular knee \n\ninjections for the treatment of degenerative cartilage lesions and osteoarthritis. \n\nKnee Surg Sports Traumatol Arthrosc. 2011;19:528-535. \n\n25. Ahmad Z, Howard D, Brooks RA, et al. The role of platelet rich plasma in \n\nmusculoskeletal science. JRSM Short Rep. 2012;3:40. \n\n26. Mishra A, Harmon K, Woodall J, et al. Sports medicine applications of \n\nplatelet rich plasma. Curr Pharm Biotechnol. 2012;13:1185-1195. \n\n27. Mishra A, Randelli P, Barr C, et al. Platelet-rich plasma and the upper \n\nextremity. Hand Clin. 2012;28:481-491. \n\n28. Zarins B. Platelet-rich plasma (PRP) \u2013 Potential orthopaedic applications \n\nof autologous preparations rich in growth factors (PRGF). Massachusetts \n\nGeneral Hospital, 2013. \n\n29. Hoareau GL, Jandrey KE, Burges J, et al. Comparison of the platelet-rich \n\nplasma and buffy coat protocols for preparation of canine platelet concentrates. \n\nVet Clin Pathol. 2014;43:513-518. \n\n30. Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix \n\nrestorative mechanisms of platelet-rich plasma in osteoarthritis.  Am J Sports \n\nMed. 2014;42:35-41. \n\n31. Cook JL, Smith PA, Bozynski CC, et al. Multiple injections of \n\nleukoreduced platelet rich plasma reduce pain and functional impairment in a \n\ncanine model of ACL and meniscal deficiency. J Orthop Res. 2015; 34:607-\n\n6015. \n\n32. Kazemi D, Fakhrjou A. Leukocyte and Platelet Rich Plasma (L-PRP) \n\nVersus Leukocyte and Platelet Rich Fibrin (L-PRF) For Articular Cartilage \n\n\n\n\t\n \u00a0\n\n25\t\n \u00a0\t\n \u00a0\n\nRepair of the Knee: A Comparative Evaluation in an Animal Model. Iran Red \n\nCrescent Med J. 2015;17:e19594. \n\n33. Xie X, Ulici V, Alexander PG, et al. Platelet-Rich Plasma Inhibits \n\nMechanically Induced Injury in Chondrocytes. Arthroscopy. 2015;31:1142-1150. \n\n34. Wiegant K, Intema F, van Roermund PM, et al. Evidence of cartilage \n\nrepair by joint distraction in a canine model of osteoarthritis. Arthritis \n\nRheumatol. 2015;67:465-474. \n\n35. Lust G, Summers BA. Early, asymptomatic stage of degenerative joint \n\ndisease in canine hip joints. Am J Vet Res. 1981;42:1849-1855. \n\n36. Boal S, Miguel Carreira L. Serum and synovial fluid C-reactive protein \n\nlevel variations in dogs with degenerative joint disease and their relationships \n\nwith physiological parameters. Vet Res Commun. 2015;39:163-169. \n\n37. Paster ER, LaFond E, Biery DN, et al. Estimates of prevalence of hip \n\ndysplasia in Golden Retrievers and Rottweilers and the influence of bias on \n\npublished prevalence figures. J Am Vet Med Assoc. 2005;226:387-392. \n\n38. Henrotin Y, Sanchez C, Balligand M. Pharmaceutical and nutraceutical \n\nmanagement of canine osteoarthritis: present and future perspectives. Vet J. \n\n2005;170:113-123. \n\n39. Fl\u00fcckiger M. Scoring radiographs for canine Hip Dysplasia - The big \n\nthree organisations in the world. European Journal Compagnion Animal \n\nPractice. 2007;17:135-140. \n\n40. Brandt KD, Dieppe P, Radin E. Etiopathogenesis of osteoarthritis. Med \n\nClin North Am. 2009;93:1-24, xv. \n\n41. Man GS, Mologhianu G. Osteoarthritis pathogenesis - a complex \n\nprocess that involves the entire joint. J Med Life. 2014;7:37-41. \n\n\n\n\t\n \u00a0\n\n26\t\n \u00a0\t\n \u00a0\n\n42. Brown DC, Boston RC, Coyne JC, et al. Ability of the canine brief pain \n\ninventory to detect response to treatment in dogs with osteoarthritis. J Am Vet \n\nMed Assoc. 2008;233:1278-1283. \n\n43. Alexander JW. The pathogenesis of canine hip dysplasia. Vet Clin North \n\nAm: Small Anim Pract. 1992;22:503-511. \n\n44. Malek S, Sample SJ, Schwartz Z, et al. Effect of analgesic therapy on \n\nclinical outcome measures in a randomized controlled trial using client-owned \n\ndogs with hip osteoarthritis. BMC Vet Res. 2012;8:185. \n\n45. Perea S. Nutritional management of osteoarthritis. Compendium on \n\nContinuing Education for the Practising Veterinarian. 2012;34:E4. \n\n46. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with \n\nrelevance for clinical practice.The Lancet. 2011;377:2115-2126. \n\n47. Teixeira LR. Owner assessment of chronic pain and gait analysis of dogs \n\nwith hip dysplasia treated with acupuncture. Botucatu Medical School. Botucatu \n\n-SP: S\u00e3o Paulo State University, 2015. \n\n48. Holton LL, Scott EM, Nolan AM, et al. Comparison of three methods \n\nused for assessment of pain in dogs. J Am Vet Med Assoc. 1998;212:61-66. \n\n49. Brown DC, Boston RC, Coyne JC, et al. Development and psychometric \n\ntesting of an instrument designed to measure chronic pain in dogs with \n\nosteoarthritis. Am J Vet Res. 2007;68:631-637. \n\n50. Anderson AF, Smith M. Progress in cartilage restoration. Am J Sports \n\nMed. 2009;37 Suppl 1:7S-9S. \n\n51. Smyth NA, Murawski CD, Haleem AM, et al. Establishing proof of \n\nconcept: Platelet-rich plasma and bone marrow aspirate concentrate may \n\n\n\n\t\n \u00a0\n\n27\t\n \u00a0\t\n \u00a0\n\nimprove cartilage repair following surgical treatment for osteochondral lesions of \n\nthe talus. World J Orthop. 2012;3:101-108. \n\n52. Aragon CL, Hofmeister EH, Budsberg SC. Systematic review of clinical \n\ntrials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc. \n\n2007;230:514-521. \n\n53. Innes J. Diet and disease: exploring the link through nutrigenomics. Can \n\nVet J. 2006;47:68-70. \n\n54. Pereira LdV. A import\u00e2ncia do uso das c\u00e9lulas tronco para a sa\u00fade \n\np\u00fablica. Ci\u00eancia &amp; Sa\u00fade Coletiva. 2008;13:7-14. \n\n55. Haas S, Weidner N, Winkler Jr. Adult stem cell therapy in stroke. Curr \n\nOpin Neurol. 2005;18:59-64. \n\n56. Carrade DD, Borjesson DL. Immunomodulation by Mesenchymal Stem \n\nCells in Veterinary Species. Comp Med. 2013;63:207\u2013217. \n\n57. Raghunath J, Salacinski HJ, Sales KM, et al. Advancing cartilage tissue \n\nengineering: the application of stem cell technology. Curr Opin  Biotechnol. \n\n2005;16:503-509. \n\n58. Oldershaw RA. Cell sources for the regeneration of articular cartilage: \n\nthe past, the horizon and the future. Int J Exp Pathol. 2012;93:389-400. \n\n59. Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an underappreciated \n\nsource of stem cells for biotechnology. Trends Biotechnol. 2006;24:150-154. \n\n60. Grasys J, Kim BS, Pallua N. Content of Soluble Factors and \n\nCharacteristics of Stromal Vascular Fraction Cells in Lipoaspirates from \n\nDifferent Subcutaneous Adipose Tissue Depots. Aesthet Surg J. 2016. \n\n61. Church CD, Berry R, Rodeheffer MS. Isolation and study of adipocyte \n\nprecursors. Methods Enzymol. 2014;537:31-46. \n\n\n\n\t\n \u00a0\n\n28\t\n \u00a0\t\n \u00a0\n\n62. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of \n\ninflammation. Annu Rev Pathol. 2011;6:457-478. \n\n63. Zhang J, Huang X, Wang H, et al. The challenges and promises of \n\nallogeneic mesenchymal stem cells for use as a cell-based therapy. Stem Cell \n\nRes Ther. 2015;6:234. \n\n64. Mrugala D, Bony C, Neves N, et al. Phenotypic and functional \n\ncharacterisation of ovine mesenchymal stem cells: application to a cartilage \n\ndefect model. Ann Rheum Dis. 2008;67:288-295. \n\n65. Carrade DD, Lame MW, Kent MS, et al. Comparative Analysis of the \n\nImmunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem \n\nCells. Cell Med. 2012;4:1-11. \n\n66. Poncelet AJ, Vercruysse J, Saliez A, et al. Although pig allogeneic \n\nmesenchymal stem cells are not immunogenic in vitro, intracardiac injection \n\nelicits an immune response in vivo. Transplant Res. 2007;83:783-790. \n\n67. Zhang J, Bai X, Zhao B, et al. Allogeneic adipose-derived stem cells \n\npromote survival of fat grafts in immunocompetent diabetic rats. Cell  Tissue \n\nRes. 2015. \n\n68. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells \n\nsuppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. \n\nExp Hematol. 2002;30:42-48. \n\n69. Berman DM, Willman MA, Han D, et al. Mesenchymal stem cells \n\nenhance allogeneic islet engraftment in nonhuman primates. Diabetes. \n\n2010;59:2558-2568. \n\n\n\n\t\n \u00a0\n\n29\t\n \u00a0\t\n \u00a0\n\n70. Kang JW, Kang KS, Koo HC, et al. Soluble factors-mediated \n\nimmunomodulatory effects of canine adipose tissue-derived mesenchymal stem \n\ncells. Stem Cells Dev. 2008;17:681-693. \n\n71. Kim HS, Kim KH, Kim SH, et al. Immunomodulatory effect of canine \n\nperiodontal ligament stem cells on allogenic and xenogenic peripheral blood \n\nmononuclear cells. J Periodontal Implant Sci.  2010;40:265-270. \n\n72. Lee WS, Suzuki Y, Graves SS, et al. Canine bone marrow-derived \n\nmesenchymal stromal cells suppress alloreactive lymphocyte proliferation in \n\nvitro but fail to enhance engraftment in canine bone marrow transplantation. \n\nBiol Blood Marrow Transplant. 2011;17:465-475. \n\n73. Khatri M, O'Brien TD, Sharma JM. Isolation and differentiation of chicken \n\nmesenchymal stem cells from bone marrow. Stem Cells Dev. 2009;18:1485-\n\n1492. \n\n74. Moreno R, Martinez-Gonzalez I, Rosal M, et al. Characterization of \n\nmesenchymal stem cells isolated from the rabbit fetal liver. Stem Cells Dev. \n\n2010;19:1579-1588. \n\n75. Liu H, Kemeny DM, Heng BC, et al. The immunogenicity and \n\nimmunomodulatory function of osteogenic cells differentiated from \n\nmesenchymal stem cells. J Immunol. 2006;176:2864-2871. \n\n76. Cho PS, Messina DJ, Hirsh EL, et al. Immunogenicity of umbilical cord \n\ntissue derived cells. Blood. 2008;111:430-438. \n\n77. Peroni JF, Borjesson DL. Anti-inflammatory and immunomodulatory \n\nactivities of stem cells. Vet Clin North Am: Equine Pract. 2011;27:351-362. \n\n78. Le Blanc K, Rasmusson I, Gotherstrom C, et al. Mesenchymal stem cells \n\ninhibit the expression of CD25 (interleukin-2 receptor) and CD38 on \n\n\n\n\t\n \u00a0\n\n30\t\n \u00a0\t\n \u00a0\n\nphytohaemagglutinin-activated lymphocytes. Scand J Immunol. 2004;60:307-\n\n315. \n\n79. Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal Stromal Cells. Ann  \n\nN Y Acad Sci. 2009;1176:101\u2013117. \n\n80. Ahmad Z, Howard D, Brooks RA, et al. The role of platelet rich plasma in \n\nmusculoskeletal science. JRSM Short  Rep. 2012;3. \n\n81. Carneiro MO, Barbieri CuH, Neto JB. Platelet-Rich Plasma gel promotes \n\nregeneration of articular cartilage in knees of sheeps. Acta Ortop Bras. 2013;21. \n\n82. Perazzi A, Busetto R, Martinello T, et al. Description of a double \n\ncentrifugation tube method for concentrating canine platelets. BMC Vet Res. \n\n2013;9. \n\n83. Aleixo GAS, Coelho MCOC, Teixeira MN, et al. Compara\u00e7\u00e3o entre dois \n\nprotocolos para obten\u00e7\u00e3o de plasma rico em plaquetas, em c\u00e3es. Arq Bras Med \n\nVet Zootec. 2011;63:567-573. \n\n84. Thoesen MS, Berg-Foels WS, Stokol T, et al. Use of a centrifugation-\n\nbased, point-of-care device for production of canine autologous bone marrow \n\nand platelet concentrates. Am J Vet Res. 2006;67:1655-1661. \n\n85. Trichler SA, Bulla SC, Thomason J, et al. Ultra-pure platelet isolation \n\nfrom canine whole blood. BMC Vet Res. 2013;9:144. \n\n86. Dohan Ehrenfest DM, Bielecki T, Mishra A, et al. In search of a \n\nconsensus terminology in the field of platelet concentrates for surgical use: \n\nplatelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization \n\nand leukocytes. Curr Pharm Biotechnol. 2012;13:1131-1137. \n\n87. Anitua E, Sanchez M, Nurden AT, et al. Platelet-released growth factors \n\nenhance the secretion of hyaluronic acid and induce hepatocyte growth factor \n\n\n\n\t\n \u00a0\n\n31\t\n \u00a0\t\n \u00a0\n\nproduction by synovial fibroblasts from arthritic patients In: M S, ed: \n\nRheumatology. 2007;1769\u20131772. \n\n88. Brossi PM, Moreira JJ, Machado TsS, et al. Platelet-rich plasma in \n\northopedic therapy: a comparative systematic review of clinical and \n\nexperimental data in equine and human musculoskeletal lesions. BMC Vet Res. \n\n2015;11. \n\n89. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of \n\nproteins for healing and tissue regeneration. J Thromb  Haemostasis. \n\n2004;91:4-15. \n\n90. Akeda K, An HS, Okuma M, et al. Platelet-rich plasma stimulates porcine \n\narticular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis \n\nCartilage. 2006;14:1272-1280. \n\n91. Van Buul GM, Koevoet WL, Kops N, et al. Platelet-rich plasma releasate \n\ninhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports \n\nMed. 2011;39:2362-2370. \n\n92. Wei L-C, Gao S-G, Xu M, et al. A novel hypothesis: The application of \n\nplatelet-rich plasma can promote the clinical healing of white-white meniscal \n\ntears. Med Sci Monit. 2012;8:HY47-50. \n\n93. Bozynski CC, Stannard JP, Smith P, et al. Acute Management of \n\nAnterior Cruciate Ligament Injuries Using Novel Canine Models. J  Knee Surg. \n\n2015.  \n\n \n\n \n\n \n\n\t\n \u00a0\n\n\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n61\t\n \u00a0\n\n5.  CONCLUSION \n\n \n\n Both SCs and PRP were apparently beneficial to reduce chronic pain in \n\ndogs suffering from bilateral hip dysplasia for 60 days, but SCs improved most \n\nof chronic pain variables compared to PRP. The clinical benefit of both \n\ntreatments is that they produce a long term pain relief in dogs with hip \n\ndysplasia, with no apparent adverse effects. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n62\t\n \u00a0\n\n6.  REFERENCES \t\n \u00a0\n\n\t\n \u00a0(Vancouver\t\n \u00a0Citation\t\n \u00a0Style)\t\n \u00a0\n\n \n\n1. Mortellaro CM. Pathophysiology of osteoarthritis. Vet Res Comm. \n\n2003;27 Suppl 1:75-78. \n\n2. Carneiro MO, Barbieri CuH, Neto JB. Platelet-Rich Plasma gel promotes \n\nregeneration of articular cartilage in knees of sheeps. Acta Ortop Bras. 2013;21. \n\n3. Vilar JM, Morales M, Santana A, et al. Controlled, blinded force platform \n\nanalysis of the effect of intraarticular injection of autologous adipose-derived \n\nmesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs. \n\nBMC Vet Res. 2013;9. \n\n4. Black  LL, Gaynor J, Adams C, et al. Effect of intraarticular injection of \n\nautologous adipose-derived mesenchymal stem and regenerative cells on \n\nclinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther. \n\n2008;9:192-200. \n\n5. Yun S, Ku SK, Kwon YS. Adipose-derived mesenchymal stem cells and \n\nplatelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis \n\nin Beagle dogs. J Orthop Surg Res. 2016;11:9. \n\n6. Upchurch DA. Administration of adipose-derived stromal vascular \n\nfraction and platelet rich plasma in dogs with coxofemoral osteoarthritis. \n\nDepartment of Clinical Sciences, 2015. \n\n7. Anitua E, Sanchez M, Nurden AT, et al. Platelet-released growth factors \n\nenhance the secretion of hyaluronic acid and induce hepatocyte growth factor \n\nproduction by synovial fibroblasts from arthritic patients. Rheumatology. \n\n2007;46:1769-1772. \n\n\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n63\t\n \u00a0\n\n8. Cuervo B, Rubio M, Sopena J, et al. Hip Osteoarthritis in Dogs: A \n\nRandomized Study Using Mesenchymal Stem Cells from Adipose Tissue and \n\nPlasma Rich in Growth Factors. Int J Mol Sci. 2014;15:13437-13460. \n\n9. Guercio A, Marco PD, Casella S, et al. Production of canine \n\nmesenchymal stem cells from adipose tissue and their application in dogs with \n\nchronic osteoarthritis of the humeroradial joints. Cell Biol Int. 2012;36:189\u2013194. \n\n10. Black LL, Gaynor J, Gahring D, et al. Effect of adipose-derived \n\nmesenchymal stem and regenerative cells on lameness in dogs with chronic \n\nosteoarthritis of the coxofemoral joints: a randomized, double-blinded, \n\nmulticenter, controlled trial. Vet Ther. 2007;4:272-284. \n\n11. Vilar JM, Batista M, Morales M, et al. Assessment of the effect of \n\nintraarticular injection of autologous adipose-derived mesenchymal stem cells in \n\nosteoarthritic dogs using a double blinded force platform analysis. BMC Vet \n\nRes. 2014;10. \n\n12. Ahmad Z, Howard D, Brooks RA, et al. The role of platelet rich plasma in \n\nmusculoskeletal science.JRSM Short Rep. 2012;3. \n\n13. Hoareau GL, Jandrey KE, Burges J, et al. Comparison of the platelet-rich \n\nplasma and buffy coat protocols for preparation of canine platelet concentrates. \n\nVet Clin Pathol. 2014;43:513-518. \n\n14. Aleixo GAS, Coelho MCOC, Teixeira MN, et al. Compara\u00e7\u00e3o entre dois \n\nprotocolos para obten\u00e7\u00e3o de plasma rico em plaquetas, em c\u00e3es. Arq Bras  \n\nMed Vet Zootec. 2011;63:567-573. \n\n15. Dohan Ehrenfest DM, Bielecki T, Mishra A, et al. In search of a \n\nconsensus terminology in the field of platelet concentrates for surgical use: \n\n\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n64\t\n \u00a0\n\nplatelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization \n\nand leukocytes. Curr Pharm Biotechnol. 2012;13:1131-1137. \n\n16. Brossi PM, Moreira JJ, Machado TsS, et al. Platelet-rich plasma in \n\northopedic therapy: a comparative systematic review of clinical and \n\nexperimental data in equine and human musculoskeletal lesions. BMC Vet Res. \n\n2015;11. \n\n17. Perazzi A, Busetto R, Martinello T, et al. Description of a double \n\ncentrifugation tube method for concentrating canine platelets. BMC Vet Res. \n\n2013;9. \n\n18. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of \n\nproteins for healing and tissue regeneration. Thromb Haemostasis. 2004;91:4-\n\n15. \n\n19. Fl\u00fcckiger M. Scoring radiographs for canine Hip Dysplasia - The big \n\nthree organisations in the world. EJCAP. 2007;17. \n\n20. Brown DC, Boston RC, Coyne JC, et al. Development and psychometric \n\ntesting of an instrument designed to measure chronic pain in dogs with \n\nosteoarthritis. Am J Vet Res. 2007;68:631-637. \n\n21. Hielm-Bj\u00f6rkman AK, Rita H, Tulamo R-M. Psychometric testing of the \n\nHelsinki chronic pain index by completion of a questionnaire in Finnish by \n\nowners of dogs with chronic signs of pain caused by osteoarthritis. Am J Vet \n\nRes. 2009;70:727-734. \n\n22. Holton LL, Scott EM, Nolan AM, et al. Comparison of three methods \n\nused for assessment of pain in dogs. J Am Vet Med Assoc. 1998;212:61-66. \n\n\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n65\t\n \u00a0\n\n23. Teixeira LR. Owner assessment of chronic pain and gait analysis of dogs \n\nwith hip dysplasia treated with acupuncture. Botucatu Medical School. Botucatu \n\n-SP: S\u00e3o Paulo State University, 2015. \n\n24. Mokbel AN, Tookhy OSE, Shamaa AA, et al. Homing and reparative \n\neffect of intra-articular injection of autologus mesenchymal stem cells in \n\nosteoarthritic animal model. BMC Musculoskelet Disord. 2011;12. \n\n25. Kazemi D, Fakhrjou A. Leukocyte and Platelet Rich Plasma (L-PRP) \n\nVersus Leukocyte and Platelet Rich Fibrin (L-PRF) For Articular Cartilage \n\nRepair of the Knee: A Comparative Evaluation in an Animal Model. Iran Red \n\nCrescent Med J. 2015;17:e19594. \n\n26. Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix \n\nrestorative mechanisms of platelet-rich plasma in osteoarthritis.  Am J  Sports \n\nMed. 2014;42:35-41. \n\n27. Arnoczky SP, Torzilli PA. Biomechanical analysis of forces acting about \n\nthe canine hip. Am J Vet Res. 1981;42:1581-1981. \n\n28. Luna SP, Basilio AC, Steagall PV, et al. Evaluation of adverse effects of \n\nlong-term oral administration of carprofen, etodolac, flunixin meglumine, \n\nketoprofen, and meloxicam in dogs. Am J Vet Res. 2007;68:258-264. \n\n29. Malek S, Sample SJ, Schwartz Z, et al. Effect of analgesic therapy on \n\nclinical outcome measures in a randomized controlled trial using client-owned \n\ndogs with hip osteoarthritis. BMC Vet Res. 2012;8:185. \n\n30. KuKanich B. Outpatient oral analgesics in dogs and cats beyond \n\nnonsteroidal antiinflammatory drugs: an evidence-based approach. Vet Clin  \n\nNorth Am Small Anim Pract. 2013;43:1109-1125. \n\n\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n66\t\n \u00a0\n\n31. Lascelles BD, Gaynor JS, Smith ES, et al. Amantadine in a multimodal \n\nanalgesic regimen for alleviation of refractory osteoarthritis pain in dogs. J Vet \n\nIntern Med. 2008;22:53-59. \n\n32. Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal Stromal Cells. Ann N \n\nY Acad Sci. 2009;1176:101\u2013117. \n\n33. Anitua E, Sanchez M, Nurden AT, et al. Platelet-released growth factors \n\nenhance the secretion of hyaluronic acid and induce hepatocyte growth factor \n\nproduction by synovial fibroblasts from arthritic patients. Rheumatology. \n\n2007;1769\u20131772. \n\n34. Jaeger GT, Larsen S, Soli N, et al. Two years follow-up study of the pain-\n\nrelieving effect of gold bead implantation in dogs with hip-joint arthritis. Acta Vet \n\nScand. 2007;49:9. \n\n35. Mills K, Hettinga BA, Pohl MB, et al. Between-limb kinematic asymmetry \n\nduring gait in unilateral and bilateral mild to moderate knee osteoarthritis. Arch \n\nPhys Med Rehabil. 2013;94:2241-2247. \n\n36. Genevois JP, Chanoit G, Carozzo C, et al. Influence of anaesthesia on \n\ncanine hip dysplasia score. J Vet Med Physiol Pathol Clin Med. 2006;53:415-\n\n417."}]}}}